JPLA
BIIB icon

Joseph P. Lucia & Associates’s Biogen BIIB Stock Holding History

Joseph P. Lucia & Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-46
Closed -$13K – 166
2021
Q3 		$13K Hold
46
– – 0.01% 351
2021
Q2 		$16K Hold
46
– – 0.01% 339
2021
Q1 		$13K Hold
46
– – 0.01% 335
2020
Q4 		$11K Buy
+46
New +$11.9K 0.01% 328
2020
Q3 		– Sell
-46
Closed -$12K – 117
2020
Q2 		$12K Hold
46
– – 0.01% 294
2020
Q1 		$15K Buy
+46
New +$14K 0.02% 249

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Joseph P. Lucia & Associates's BIIB Position: Q4 2021 in Review

Joseph P. Lucia & Associates sold out of Biogen (BIIB) in Q4 2021, closing a stake of 46 shares — an estimated $13K sold.

Joseph P. Lucia & Associates first reported a position in BIIB in Q1 2020 and held it in 6 quarters. The position peaked at $16K in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Joseph P. Lucia & Associates reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 46 Biogen shares in Q4 2021, an estimated $13K.
  • Joseph P. Lucia & Associates first reported a position in Biogen in Q1 2020 and held it in 6 quarters.
  • Joseph P. Lucia & Associates's Biogen position peaked at $16K in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Joseph P. Lucia & Associates's 13F filing for Q4 2021, filed 4 Feb 2022.